|
Oxford Nanopore Technologies plc (ONT.L) DCF Valuation
GB | Healthcare | Biotechnology | LSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Oxford Nanopore Technologies plc (ONT.L) Bundle
Gain insights into your Oxford Nanopore Technologies plc (ONTL) valuation analysis using our sophisticated DCF Calculator! This Excel template comes preloaded with real (ONTL) data, enabling you to adjust forecasts and assumptions to accurately determine the intrinsic value of Oxford Nanopore Technologies plc.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 52.1 | 113.9 | 133.7 | 198.6 | 169.7 | 233.9 | 322.4 | 444.5 | 612.7 | 844.6 |
| Revenue Growth, % | 0 | 118.7 | 17.39 | 48.59 | -14.57 | 37.85 | 37.85 | 37.85 | 37.85 | 37.85 |
| EBITDA | -65.0 | -55.1 | -140.3 | -49.7 | -105.7 | -157.0 | -216.5 | -298.4 | -411.3 | -567.1 |
| EBITDA, % | -124.9 | -48.37 | -105 | -25.01 | -62.3 | -67.14 | -67.14 | -67.14 | -67.14 | -67.14 |
| Depreciation | 14.8 | 17.3 | 24.7 | 31.9 | 41.6 | 48.1 | 66.3 | 91.4 | 126.0 | 173.6 |
| Depreciation, % | 28.51 | 15.22 | 18.47 | 16.05 | 24.53 | 20.56 | 20.56 | 20.56 | 20.56 | 20.56 |
| EBIT | -79.9 | -72.4 | -165.0 | -81.5 | -147.3 | -183.1 | -252.5 | -348.0 | -479.7 | -661.3 |
| EBIT, % | -153.42 | -63.59 | -123.47 | -41.06 | -86.84 | -78.3 | -78.3 | -78.3 | -78.3 | -78.3 |
| Total Cash | 13.1 | 80.9 | 618.5 | 476.2 | 270.1 | 185.3 | 255.5 | 352.2 | 485.5 | 669.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 66.0 | 50.9 | 38.5 | 41.2 | 33.8 | 100.2 | 138.1 | 190.4 | 262.4 | 361.8 |
| Account Receivables, % | 126.73 | 44.7 | 28.78 | 20.74 | 19.94 | 42.83 | 42.83 | 42.83 | 42.83 | 42.83 |
| Inventories | 20.0 | 35.6 | 63.1 | 87.7 | 101.5 | 103.4 | 142.5 | 196.4 | 270.8 | 373.3 |
| Inventories, % | 38.48 | 31.29 | 47.19 | 44.16 | 59.85 | 44.19 | 44.19 | 44.19 | 44.19 | 44.19 |
| Accounts Payable | 12.0 | 31.0 | 20.5 | 23.1 | 25.2 | 43.0 | 59.3 | 81.8 | 112.7 | 155.4 |
| Accounts Payable, % | 22.96 | 27.23 | 15.33 | 11.63 | 14.84 | 18.4 | 18.4 | 18.4 | 18.4 | 18.4 |
| Capital Expenditure | -30.3 | -26.5 | -30.8 | -42.2 | -27.3 | -66.3 | -91.5 | -126.1 | -173.8 | -239.6 |
| Capital Expenditure, % | -58.18 | -23.25 | -23.06 | -21.27 | -16.08 | -28.37 | -28.37 | -28.37 | -28.37 | -28.37 |
| Tax Rate, % | -3.16 | -3.16 | -3.16 | -3.16 | -3.16 | -3.16 | -3.16 | -3.16 | -3.16 | -3.16 |
| EBITAT | -71.7 | -60.6 | -166.6 | -89.0 | -152.0 | -173.4 | -239.0 | -329.5 | -454.3 | -626.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -161.2 | -51.2 | -198.3 | -124.1 | -142.1 | -242.0 | -325.0 | -448.0 | -617.6 | -851.3 |
| WACC, % | 8.64 | 8.63 | 8.66 | 8.66 | 8.66 | 8.65 | 8.65 | 8.65 | 8.65 | 8.65 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1,852.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -868 | |||||||||
| Terminal Value | -13,057 | |||||||||
| Present Terminal Value | -8,623 | |||||||||
| Enterprise Value | -10,476 | |||||||||
| Net Debt | -179 | |||||||||
| Equity Value | -10,297 | |||||||||
| Diluted Shares Outstanding, MM | 834 | |||||||||
| Equity Value Per Share | -1,234.74 |
What You Will Receive
- Authentic ONTL Financial Data: Pre-loaded with Oxford Nanopore Technologies' historical and projected figures for accurate analysis.
- Completely Customizable Template: Easily adjust key inputs such as revenue growth, WACC, and EBITDA percentages.
- Instant Calculations: Observe real-time updates of Oxford Nanopore's intrinsic value based on your modifications.
- Expert Valuation Tool: Tailored for investors, analysts, and consultants who require precise DCF evaluations.
- Intuitive Design: Clear layout and straightforward instructions suitable for users of all levels.
Key Features
- 🔍 Real-Life ONTL Financials: Pre-filled historical and projected data for Oxford Nanopore Technologies plc.
- ✏️ Fully Customizable Inputs: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Integrated formulas compute the intrinsic value of Oxford Nanopore Technologies using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize ONTL's valuation immediately after making adjustments.
- Scenario Analysis: Evaluate and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the prebuilt Excel template featuring Oxford Nanopore Technologies plc’s (ONTL) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Revise forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly observe recalibrated results, including Oxford Nanopore's intrinsic value.
- Step 5: Make well-informed investment choices or create reports based on the generated outputs.
Why Opt for This Calculator?
- Precision: Utilizes actual financial figures from Oxford Nanopore Technologies plc (ONTL) for reliable data.
- Adaptability: Engineered to allow users to experiment and adjust inputs with ease.
- Efficient: Avoid the complexities of constructing a DCF model from the ground up.
- Expert-Level: Crafted with a focus on CFO-level accuracy and user experience.
- Intuitive: Simple to navigate, even for those without extensive financial modeling skills.
Who Can Benefit from This Product?
- Research Scientists: Develop precise and reliable sequencing protocols for experimental analysis.
- Genomics Professionals: Assess genetic data to inform research and clinical decisions.
- Healthcare Consultants: Offer clients informed insights into the genomic landscape related to ONT (ONTL) technologies.
- Students and Educators: Utilize real-time data to enhance learning and teaching in genomics and bioinformatics.
- Biotechnology Enthusiasts: Gain a deeper understanding of how companies like Oxford Nanopore are innovating in the market.
What the Template Contains
- Historical Data: Includes Oxford Nanopore Technologies' past financials and baseline forecasts.
- DCF and Levered DCF Models: Comprehensive templates for calculating the intrinsic value of Oxford Nanopore Technologies (ONTL).
- WACC Sheet: Pre-constructed calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Adjust key metrics such as growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A thorough analysis of Oxford Nanopore Technologies' financial performance.
- Interactive Dashboard: Dynamically visualize valuation outcomes and projections.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.